An Investigation Into the Prevalence, Cause and treatment of Unexplained Anamia in Diabetes - Anamia and Diabetes

Conditions: Anaemia in Diabetes

Registration Number: EUCTR2005-003057-28-GB

Lead Sponsor: niversity Hospital Aintree NHS Trust

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Authorised-recruitment may be ongoing or finished

Sex: All

Target Recruitment: Not specified

Inclusion Criteria

Patients must have diabetes mellitus

Patients in active attendance at a designated care centre i.e. at least one visit in the last 6-12 months

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients aged <18years old

Patients unwilling to participate in the study

Patients with known cause of anaemia

Patients with severe uncontrolled blood pressure

Patients with evidence of cardiac decompensation

Study & Design

Study Type: Interventional clinical trial of medicinal product

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: To determine the response of diabetic patients with anaemia of unknown origin to erythropoietin therapy;Secondary Objective: To determine the impact of anaemia and it's treatment on the patient's quality of life;Primary end point(s): Rise in Haemoglobin levels

Secondary Outcome Measures